ストックスクリーナーアプリを入手
31.02
10.84%
-3.77
プレマーケット:
33.00
1.98
+6.38%
前日終値:
$34.79
開ける：
$32.9
24時間の取引高:
61,359
Relative Volume:
0.21
時価総額：
$39.14M
収益：
-
当期純損益:
$-26.82M
株価収益率:
-2.9124
EPS:
-10.6509
ネットキャッシュフロー:
$-24.28M
1週間 パフォーマンス:
+15.40%
1か月 パフォーマンス:
+4.06%
6か月 パフォーマンス:
+230.00%
1年 パフォーマンス:
+323.77%
1日の値動き範囲:
$30.04
$36.07
1週間の範囲:
$22.98
$36.07
52週間の値動き範囲:
$5.21
$36.76
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
名前
Sensei Biotherapeutics Inc
セクター
電話
(240) 243-8000
住所
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE vs VRTX, REGN, ARGX, ALNY, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
31.02 | 39.14M | 0 | -26.82M | -24.28M | -10.65 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | 再開されました | H.C. Wainwright | Buy |
| 2024-05-14 | 開始されました | Stephens | Overweight |
| 2021-07-01 | ダウングレード | Berenberg | Buy → Hold |
| 2021-06-29 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-03-01 | 開始されました | Berenberg | Buy |
| 2021-03-01 | 開始されました | Citigroup | Buy |
| 2021-03-01 | 開始されました | Oppenheimer | Outperform |
| 2021-03-01 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Sensei Biotherapeutics Inc (SNSE) 最新ニュース
Investor Mood: What is the Moat Score of Sensei Biotherapeutics IncQuarterly Profit Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Sidley Represents Sensei Biotherapeutics in Acquisition of Faeth Therapeutics - Legal Desire Media and Insights
AI Stocks: Can Sensei Biotherapeutics Inc grow without dilution2026 Catalysts & Trade Opportunity Analysis Reports - baoquankhu1.vn
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update - biospace.com
Sensei Biotherapeutics (SNSE) Sets Ambitious Clinical Goals for 2026 - GuruFocus
Faeth acquisition and $200M raise reshape Sensei Biotherapeutics (NASDAQ: SNSE) - stocktitan.net
Sensei Biotherapeutics Acquires Faeth, Advances PIKTOR Cancer Program with $200M Financing and Reports 2025 Financial Results - Minichart
Sensei Biotherapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update - TradingView
Sensei Biotherapeutics (NASDAQ: SNSE) 2025 loss narrows, lands $200M - stocktitan.net
Aug Chart Watch: What is Sensei Biotherapeutics Incs TAM Total Addressable Market2026 WrapUp & Real-Time Market Trend Scan - baoquankhu1.vn
If You Invested $1,000 in Sensei Biotherapeutics, Inc. (SNSE) - stocktitan.net
Decliners Report: Does Sensei Biotherapeutics Inc have pricing power2026 Sector Review & Long-Term Safe Investment Plans - baoquankhu1.vn
Aug Technicals: What is the Moat Score of Sensei Biotherapeutics Inc2026 PreEarnings & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Momentum Shift: Can Sensei Biotherapeutics Inc be the next market leaderWeekly Profit Recap & Capital Efficient Trade Techniques - baoquankhu1.vn
SNSE.O PE Ratio & Valuation, Is SNSE.O Overvalued - Intellectia AI
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology - GlobeNewswire Inc.
Anand Kiran Parikh Net Worth (2026) - GuruFocus
Sensei Biotherapeutics announces inducement grants under Nasdaq listing rule - TipRanks
Sensei Biotherapeutics (SNSE) Announces Stock Option Grant to Ne - GuruFocus
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Sensei Biotherapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Why Sensei Biotherapeutics Inc. stock is favored by pension funds2026 Pullbacks & Reliable Entry Point Trade Alerts - Naître et grandir
Update Recap: How buybacks impact Sensei Biotherapeutics Inc. stock valueCEO Change & Comprehensive Market Scan Insights - Naître et grandir
Published on: 2026-03-07 01:25:22 - Naître et grandir
Can Sensei Biotherapeutics Inc be the next market leaderQuarterly Profit Review & Technical Confirmation Alerts - baoquankhu1.vn
Rate Hike: Is Sensei Biotherapeutics Inc a strong growth stockMarket Activity Recap & Stepwise Trade Execution Plans - baoquankhu1.vn
Fed Meeting: Whats next for CRWD stock2025 Market WrapUp & Accurate Entry/Exit Alerts - baoquankhu1.vn
Trails Edge Capital Partners, LP Acquires Shares in Sensei Bioth - GuruFocus
Revenue Check: Is Sensei Biotherapeutics Inc being accumulated by smart moneyWeekly Gains Summary & Accurate Buy Signal Notifications - baoquankhu1.vn
Sensei Biotherapeutics grants stock options to 17 new employees - Investing.com
SNSE (NASDAQ: SNSE) insider schedules sale of 3,374 shares; prior sale 42,594 - Stock Titan
SNSE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sensei Biotherapeutics Acquires Faeth Therapeutics and Raises US$200 Million in Private Placement - globallegalchronicle.com
SNSESensei Biotherapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Sensei Biotherapeutics Merges with Faeth Therapeutics, Secures $200M Funding - National Today
What is Sensei Biotherapeutics Inc. s revenue forecastJuly 2025 Trade Ideas & Precise Buy Zone Tips - mfd.ru
Sensei Biotherapeutics Acquires Faeth Therapeutics - Global Legal Chronicle
Sensei Biotherapeutics (SNSE) COO and director added as SEC insider - Stock Titan
Sensei Biotherapeutics Closes Faeth Acquisition and Financing - The Globe and Mail
Sensei Biotherapeutics Secures Future with Faeth Therapeutics Acquisition and $200M Financing - Beijing Times
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition - MSN
Sensei Biotherapeutics Acquires Faeth Therapeutics and Secures $200 Million Funding - El-Balad.com
Sensei Biotherapeutics PIPE in Connection with its Acquisition of Faeth Therapeutics - Leerink Partners
Sensei/Faeth Merger Will Keep Both Firms’ Cancer Pipelines Active - Citeline News & Insights
Merger deal renews Faeth in Sensei; Piktor brightens, stock jumps - BioWorld MedTech
Small Cap Stocks To Add to Your WatchlistFebruary 18th - MarketBeat
Sensei Biotherapeutics Stock Soars 230% After Faeth Deal - Bitget
Why Is Sensei Biotherapeutics Stock Skyrocketing Wednesday?Sensei Biotherapeutics (NASDAQ:SNSE) - Benzinga
Sensei Biotherapeutics (SNSE) Shares Soar After $200M Acquisitio - GuruFocus
Sensei Biotherapeutics Inc (SNSE) 財務データ
収益
当期純利益
現金流量
EPS
0.49%
1.47%
大文字化:
|
ボリューム (24 時間):